- Home
- SGC vs HRTX Comparison
SGC vs HRTX Comparison
Compare SGC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- HRTX
- Stock Information
- Founded
- SGC 1920
- HRTX 1983
- Country
- SGC United States
- HRTX United States
- Employees
- SGC N/A
- HRTX N/A
- Industry
- SGC Apparel
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- SGC Consumer Discretionary
- HRTX Health Care
- Exchange
- SGC Nasdaq
- HRTX Nasdaq
- Market Cap
- SGC 281.4M
- HRTX 270.7M
- IPO Year
- SGC N/A
- HRTX 1987
- Fundamental
- Price
- SGC $10.80
- HRTX $2.38
- Analyst Decision
- SGC Strong Buy
- HRTX Strong Buy
- Analyst Count
- SGC 2
- HRTX 3
- Target Price
- SGC $19.00
- HRTX $5.67
- AVG Volume (30 Days)
- SGC 59.9K
- HRTX 2.7M
- Earning Date
- SGC 03-11-2025
- HRTX 05-06-2025
- Dividend Yield
- SGC 5.09%
- HRTX N/A
- EPS Growth
- SGC 35.19
- HRTX N/A
- EPS
- SGC 0.73
- HRTX N/A
- Revenue
- SGC $565,676,000.00
- HRTX $144,285,000.00
- Revenue This Year
- SGC $5.04
- HRTX $11.81
- Revenue Next Year
- SGC $5.54
- HRTX $15.79
- P/E Ratio
- SGC $15.08
- HRTX N/A
- Revenue Growth
- SGC 4.12
- HRTX 13.57
- 52 Week Low
- SGC $10.75
- HRTX $1.04
- 52 Week High
- SGC $21.80
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- SGC 21.95
- HRTX 58.92
- Support Level
- SGC $10.74
- HRTX $2.29
- Resistance Level
- SGC $11.76
- HRTX $2.56
- Average True Range (ATR)
- SGC 0.55
- HRTX 0.20
- MACD
- SGC -0.20
- HRTX -0.01
- Stochastic Oscillator
- SGC 5.18
- HRTX 46.43
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.